Form 8-K - Current report:
SEC Accession No. 0001564590-20-015011
Filing Date
2020-04-02
Accepted
2020-04-02 16:55:58
Documents
5
Period of Report
2020-04-02
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K fate-8k_20200402.htm 8-K 59967
2 EX-99.1 fate-ex991_7.htm EX-99.1 15797
3 EX-99.2 fate-ex992_6.htm EX-99.2 22245
4 GRAPHIC gon0sesyc2gq000001.jpg GRAPHIC 3661
5 GRAPHIC gsyk0wteeceu000001.jpg GRAPHIC 4199
  Complete submission text file 0001564590-20-015011.txt   110452
Mailing Address 3535 GENERAL ATOMICS COURT SUITE 200 SAN DIEGO CA 92121
Business Address 3535 GENERAL ATOMICS COURT SUITE 200 SAN DIEGO CA 92121 858.875.1803
FATE THERAPEUTICS INC (Filer) CIK: 0001434316 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36076 | Film No.: 20769858
SIC: 2836 Biological Products, (No Diagnostic Substances)